476 related articles for article (PubMed ID: 22289780)
1. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.
Guo S; Liu M; Wang G; Torroella-Kouri M; Gonzalez-Perez RR
Biochim Biophys Acta; 2012 Apr; 1825(2):207-22. PubMed ID: 22289780
[TBL] [Abstract][Full Text] [Related]
2. Leptin-cytokine crosstalk in breast cancer.
Newman G; Gonzalez-Perez RR
Mol Cell Endocrinol; 2014 Jan; 382(1):570-582. PubMed ID: 23562747
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic role and therapeutic target of leptin signaling in colorectal cancer.
Zhou W; Tian Y; Gong H; Guo S; Luo C
Expert Opin Ther Targets; 2014 Aug; 18(8):961-71. PubMed ID: 24946986
[TBL] [Abstract][Full Text] [Related]
4. Leptin signaling molecular actions and drug target in hepatocellular carcinoma.
Jiang N; Sun R; Sun Q
Drug Des Devel Ther; 2014; 8():2295-302. PubMed ID: 25484575
[TBL] [Abstract][Full Text] [Related]
5. The multifactorial role of leptin in driving the breast cancer microenvironment.
Andò S; Catalano S
Nat Rev Endocrinol; 2011 Nov; 8(5):263-75. PubMed ID: 22083089
[TBL] [Abstract][Full Text] [Related]
6. Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells.
Bartucci M; Svensson S; Ricci-Vitiani L; Dattilo R; Biffoni M; Signore M; Ferla R; De Maria R; Surmacz E
Endocr Relat Cancer; 2010 Sep; 17(3):823-33. PubMed ID: 20603394
[TBL] [Abstract][Full Text] [Related]
7. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
Guo S; Gonzalez-Perez RR
PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
[TBL] [Abstract][Full Text] [Related]
9. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
[TBL] [Abstract][Full Text] [Related]
10. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
11. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
[TBL] [Abstract][Full Text] [Related]
12. Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells.
Feldman DE; Chen C; Punj V; Tsukamoto H; Machida K
Proc Natl Acad Sci U S A; 2012 Jan; 109(3):829-34. PubMed ID: 22207628
[TBL] [Abstract][Full Text] [Related]
13. Linkage Between Obesity Leptin and Breast Cancer.
Atoum MF; Alzoughool F; Al-Hourani H
Breast Cancer (Auckl); 2020; 14():1178223419898458. PubMed ID: 31975779
[TBL] [Abstract][Full Text] [Related]
14. Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis.
Taliaferro-Smith L; Nagalingam A; Knight BB; Oberlick E; Saxena NK; Sharma D
Neoplasia; 2013 Jan; 15(1):23-38. PubMed ID: 23358729
[TBL] [Abstract][Full Text] [Related]
15. Leptin's Pro-Angiogenic Signature in Breast Cancer.
Gonzalez-Perez RR; Lanier V; Newman G
Cancers (Basel); 2013 Sep; 5(3):1140-62. PubMed ID: 24202338
[TBL] [Abstract][Full Text] [Related]
16. Signaling Pathways Induced by Leptin during Epithelial⁻Mesenchymal Transition in Breast Cancer.
Olea-Flores M; Juárez-Cruz JC; Mendoza-Catalán MA; Padilla-Benavides T; Navarro-Tito N
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404206
[TBL] [Abstract][Full Text] [Related]
17. Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.
Nyasani E; Munir I; Perez M; Payne K; Khan S
Endocrine; 2019 Jan; 63(1):3-17. PubMed ID: 30218381
[TBL] [Abstract][Full Text] [Related]
18. Role of leptin and leptin receptors in hematological malignancies.
Uddin S; Mohammad RM
Leuk Lymphoma; 2016; 57(1):10-6. PubMed ID: 26077362
[TBL] [Abstract][Full Text] [Related]
19. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.
Lipsey CC; Harbuzariu A; Daley-Brown D; Gonzalez-Perez RR
World J Methodol; 2016 Mar; 6(1):43-55. PubMed ID: 27019796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
